P53 expression in breast cancer

International Journal of Cancer

Volumn 41, Issue 2, 1988, Pages 178-183

  Cattoretti, Giorgio ^a   Rilke, Franco ^a   Andreola, Salvatore ^a   D'Amato, Lucia ^a   Delia, Domenico ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P53;

BREAST CANCER; DIAGNOSIS; FEMALE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMAN; MALE; MIDDLE AGE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PLOIDIES; PROTEIN P53; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0023925894     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910410204     Document Type: Article

References (44)

1. Immunologically distinct p53 molecules generated by alternative splicing
2. Isolation of human p53 specific monoclonal antibodies and their use in the study of human p53 expression
3. Analysis of the gene coding for the murine cellular tumour antigen p53
4. Histological grading and prognosis in breast cancer
5. Monomorphic anti‐HLA‐A,B,C, monoclonal antibodies detecting molecular subunits and combinatorial determinants
6. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B‐cell lymphoma
7. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
8. The cellular protein p53 in human tumours
9. Relationship between ERICA and conventional steroid receptor assays in breast cancer
10. p53 transformation‐related protein: detection by monoclonal antibody in mouse and human cells
11. The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens
12. Heterogeneous expression of cell‐surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies
13. Overproduction of p53 antigen makes established cells highly tumorigenic
14. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
15. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki‐67
16. Cell cycle analysis of a cell proliferation‐associated human nuclear antigen defined by the monoclonal antibody Ki‐67
17. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
18. + monocytic cells in the tumor stroma
19. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies
20. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF‐7 breast cancer cells
21. The cellular oncogene p53 can be activated by mutagenesis
22. T antigen is bound to a host protein in SV40‐transformed cells
23. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast
24. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes
25. Microinjection of monoclonal antibody to protein p53 inhibits seruminduced DNA synthesis in 3T3 cells
26. Different forms of p53 detected by monoclonal antibodies in non‐dividing lymphocytes
27. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
28. The p53 cellular tumor antigen: gene structure, expression and protein properties
29. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
30. Specific interaction between the p53 tumour antigen and major heat shock proteins
31. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
32. p53, a transformation‐related cellular‐encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells
33. p53 transformation‐related protein accumulates in the nucleus of transformed fibroblasts in association with chromatin and is found in the cytoplasm of non‐transformed fibroblasts
34. Variation in antigenic determinants of p53 transformation‐related protein obtained from various species
35. Epidermal‐growth‐factor receptor status as predictor of early recurrence of and death from breast cancer
36. Epidermal‐growth‐factor receptors and oestrogen receptors in human breast cancer
37. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer
38. The cell kinetics of breast cancer
39. Expression of the p53 oncogene in acute myeloblastic leukemia
40. Use of freezedried paraffin‐embedded sections for immunohistologic staining with monoclonal antibodies
41. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer
42. A detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis
43. Monoclonal antibody analysis of p53 expression in normal and transformed cells